Skip to main content
. 2021 May 7;36(11):1746–1755. doi: 10.1007/s00380-021-01861-8

Table 2.

Procedural characteristics. All measures expressed as n (%), mean (SD) or median with interquartile range (quartile 1 to quartile 3)

Variable Overall
(n = 596)
No PPMI
(n = 125)
PPMI
(n = 471)
p value
Valve type  < 0.001
SAPIEN XT 29 (4.9) 9 (7.2) 20 (4.2)
SAPIEN 3 285 (47.8) 71 (56.8) 214 (45.4)
SAPIEN 3 ULTRA 54 (9.1) 17 (13.6) 37 (7.9)
CoreValve 70 (11.7) 6 (4.8) 64 (13.6)
Evolut R 58 (9.7) 5 (4.0) 53 (11.3)
Evolut PRO 85 (14.3) 15 (12.0) 70 (14.9)
ACURATE neo 10 (1.7) 1 (0.8 9 (1.9)
NVT ALLEGRA 5 (0.8) 1 (0.8) 4 (0.8)
Vascular access
Femoral 551 (92.4) 120 (96.0) 436 (92.6) 0.407
Transapical 15 (2.5) 2 (1.6) 13 (2.8)
Subclavian 30 (5.0) 5 (4.0) 25 (5.3)
Valve-in-valve 18 (3.0) 5 (4.0) 13 (2.8) 0.670
Pre-dilatation 336 (56.4) 64 (51.2) 272 (57.7) 0.341
Post-dilatation 57 (9.6) 11 (8.8) 46 (9.8) 0.944
Rapid pacing 505 (84.7) 111 (88.8) 394 (83.7) 0.301
Procedural time 113.0 (86.0 to 146.0) 117.0 (87.0 to 140.8) 111.00 (86.0 to 147.0) 0.760

PPMI post-procedure myocardial injury